Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Integrated care

Integrated NHS finances: what do they mean for High Cost Drugs?

Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs

Wilmington Healthcare

How will the Tories’ historic win shape the NHS?

Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond

Wilmington Healthcare

- PMLiVE

NHS tackles care home over-medication

Integrated care systems lead change

Putting disease prevention on a par with cure

Steve How and Paul Midgley, of the Wilmington Healthcare Consulting Team, explore how the NHS is taking an increasingly holistic approach to care

Wilmington Healthcare

What does the new NHS plan mean for pharma?

Steve How and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of the NHS Long-term Plan

Wilmington Healthcare

How can the NHS deliver integrated care?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain the changes needed to help the NHS provide a more holistic, joined up experience for patients

Wilmington Healthcare

How the focus on patient outcomes has allowed FMCG to enter into healthcare market

Associate Consultant Mette Drabæk talks about how the increase in ability to measure real-world patient outcomes has strengthened the position of the payer when negotiating reimbursement contracts with pharma companies.

Blue Latitude Health

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links